Ocular Therapeutix, Inc. (OCUL) is a publicly traded Healthcare sector company. As of May 21, 2026, OCUL trades at $8.08 with a market cap of $1.83B and a P/E ratio of -5.63. OCUL moved +0.38% today. Year to date, OCUL is -30.48%; over the trailing twelve months it is +5.66%. Its 52-week range spans $5.79 to $16.44. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces OCUL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ocular Therapeutix, Inc. (OCUL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OCUL moved +0.38% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $8.08 |
| Market Cap | $1.83B |
| P/E Ratio | -5.63 |
| EPS | $-1.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.44 |
| 52-Week Low | $5.79 |
| Volume | 4.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $52.04M |
| Net Income | $-290.50M |
| Gross Margin | 87.24% |
9 analysts cover OCUL: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.